Literature DB >> 17686052

The risk associated with indwelling catheters in children with haemophilia.

Rolf Ljung1.   

Abstract

Infections are the most frequent complications associated with the use of central venous lines (CVLs) in children with haemophilia. Several retrospective studies that include data from a substantial number of patients have reported approximately 0.2-0.3 infections per 1000 catheter-days (mainly Port-A-Cath). Some studies have shown a much higher frequency of infections, 1-2/1000 catheter-days. The most plausible explanations, for the difference seen in frequency of infections with Port-A-Caths, are probably related to the protocol used for the device care and the quality of education and the compliance of the users, whether these are parents or health-care professionals. The figures are low for clinically apparent thrombosis in the larger series on record, but routine venograms were not performed in most of these series. In studies, where this has been performed, a high frequency of abnormalities (>50%) on venograms have been seen in some series but not in others. Despite obvious potential risks with CVLs, they are useful in many cases and facilitate the treatment of a serious disorder. With careful guidelines and surveillance protocols, the risk of complications should be reduced in the future.

Entities:  

Mesh:

Year:  2007        PMID: 17686052     DOI: 10.1111/j.1365-2141.2007.06703.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.

Authors:  Annelies Nijdam; Carmen Altisent; Manuel D Carcao; Ana R Cid; Ségolène Claeyssens-Donadel; Karin Kurnik; Rolf Ljung; Beatrice Nolan; Pia Petrini; Helen Platokouki; Anne Rafowicz; Angela E Thomas; Kathelijn Fischer
Journal:  Haematologica       Date:  2014-12-19       Impact factor: 9.941

Review 2.  Current and evolving features in the clinical management of haemophilia.

Authors:  Antonio Coppola; Massimo Morfini; Ernesto Cimino; Antonella Tufano; Anna M Cerbone; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

3.  Population Pharmacokinetic Analysis and Exploratory Exposure-Bleeding Rate Relationship of Emicizumab in Adult and Pediatric Persons with Hemophilia A.

Authors:  Sylvie Retout; Christophe Schmitt; Claire Petry; François Mercier; Nicolas Frey
Journal:  Clin Pharmacokinet       Date:  2020-12       Impact factor: 6.447

4.  Treatment of hemophilia: a review of current advances and ongoing issues.

Authors:  Antonio Coppola; Mirko Di Capua; Matteo Nicola Dario Di Minno; Mariagiovanna Di Palo; Emiliana Marrone; Paola Ieranò; Claudia Arturo; Antonella Tufano; Anna Maria Cerbone
Journal:  J Blood Med       Date:  2010-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.